SCHEMBL22450127

SCHEMBL22450127

CCOC(=O)Nc1ccoc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.50
RAB9A P51151 4/20 0.50
HPGD P15428 3/20 0.50
CYP1A2 P05177 2/20 0.50
CYP2C9 P11712 2/20 0.50
CYP2C19 P33261 2/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
HTT P42858 1/20 0.50
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
HSD17B10 Q99714 3/20 0.49
LMNA P02545 2/20 0.49
MAPK1 P28482 2/20 0.49
MAPT P10636 1/20 0.49
KDM4E B2RXH2 4/20 0.49
SMN1; SMN2 Q16637 5/20 0.47
ALDH1A1 P00352 5/20 0.47
POLB P06746 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25528978 0.82 TSHR (0.57) RAB9AHPGDHSD17B10LMNAMAPK1
SCHEMBL3122553 0.82 SMN1; SMN2 (0.54) HPGDHTTHSD17B10LMNAMAPK1
SCHEMBL7565510 0.79 RAB9A (0.71) NPC1RAB9AHPGDCYP1A2CYP2C9
SCHEMBL190015 0.76 CA12 (0.45) NPC1RAB9ASMN1; SMN2
SCHEMBL190346 0.75
SCHEMBL11767621 0.75 KDM4E (0.70) NPC1RAB9AHPGDCYP1A2CYP2C9
Ethyl Phenylcarbamate SCHEMBL264865 0.74 RAB9A (0.75) NPC1RAB9AHPGDCYP2C9CYP2C19
SCHEMBL7565512 0.74 RAB9A (0.70) NPC1RAB9AHPGDCYP1A2CYP2C9
Ethyl Phenylcarbamate SCHEMBL11593824 0.74 RAB9A (0.75) NPC1RAB9AHPGDCYP2C9CYP2C19
SCHEMBL9146676 0.74 LMNA (0.68) NPC1RAB9AHPGDCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2947084-B1 FIVE-AND-SIX-MEMBERED HETEROCYCLIC COMPOUND, AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF GUANGZHOU MAXINOVEL PHARMACEUTICALS CO (CN) 2020-09-23 EP disclosed